ERNESTINA KYEI-DONKOR: Open Payments
NPI 1255428199 · WINTER PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,398 in 134 payments from 25 companies in 2025. Trend: 2023 $3,623 · 2024 $3,959 · 2025 $4,398
Food & beverage: $4,353Education: $45
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $500 |
| ABBVIE INC. | 20 | $484 |
| Janssen Biotech, Inc. | 15 | $467 |
| AstraZeneca Pharmaceuticals LP | 10 | $418 |
| UCB, Inc. | 22 | $401 |
| Gilead Sciences, Inc. | 2 | $259 |
| GENZYME CORPORATION | 9 | $243 |
| ABIOMED | 2 | $229 |
| PFIZER INC. | 13 | $205 |
| Edwards Lifesciences Corporation | 1 | $154 |
Products named: TREMFYA, RINVOQ, Bimzelx, XELJANZ, KEVZARA, SAPHNELO, SYMPLICITY G3, EVENITY.
Industry payments across FL — which companies pay providers there.
